Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Universal Electronics
UEIC
$69.2M
| $8.11M | 0.01% |
155,123
+42,900
| +38% | +$2.3M |
|
1577
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $8.1M | 0.01% |
238,254
+219,904
| +1,198% | +$7.37M |
|
|
CHUY
1578
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $8.1M | 0.01% |
312,494
+48,594
| +18% | +$1.26M |
|
|
FPRX
1579
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.09M | 0.01% |
1,761,971
+427,080
| +32% | +$1.69M |
|
|
MAXR
1580
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $8.07M | 0.01% |
+515,302
| New | +$5.35M |
|
1581
Fossil Group
FOSL
$324M
| $8.04M | 0.01% |
1,020,748
-245,902
| -19% | -$2.27M |
|
1582
CTS Corp
CTS
$1.81B
| $8.04M | 0.01% |
267,900
+14,900
| +6% | +$432K |
|
1583
Shore Bancshares
SHBI
$799M
| $8.03M | 0.01% |
462,353
+15,158
| +3% | +$248K |
|
1584
Champion Homes
SKY
$5.17B
| $8.02M | 0.01% |
253,120
+235,320
| +1,322% | +$7.33M |
|
1585
C&F Financial
CFFI
$286M
| $8.02M | 0.01% |
145,000
+2,100
| +1% | +$112K |
|
|
MRTX
1586
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8M | 0.01% |
62,100
-293,800
| -83% | -$28.3M |
|
|
SAGE
1587
DELISTED
Sage Therapeutics
SAGE
| $7.98M | 0.01% |
+110,591
| New | +$13.6M |
|
|
PBPB
1588
DELISTED
Potbelly
PBPB
| $7.98M | 0.01% |
1,890,500
-19,300
| -1% | -$84.2K |
|
1589
Stratasys
SSYS
$779M
| $7.97M | 0.01% |
394,152
-600,980
| -60% | -$12M |
|
1590
G. Willi-Food International
WILC
$394M
| $7.96M | 0.01% |
665,812
+1,000
| +0.2% | +$11.5K |
|
1591
Installed Building Products
IBP
$6.43B
| $7.94M | 0.01% |
115,300
+74,397
| +182% | +$5.02M |
|
1592
Kirby Corp
KEX
$7.28B
| $7.93M | 0.01% |
+88,600
| New | +$7.34M |
|
1593
Brinker International
EAT
$10.2B
| $7.93M | 0.01% |
188,711
+177,311
| +1,555% | +$7.64M |
|
|
SMMF
1594
DELISTED
Summit Financial Group, Inc.
SMMF
| $7.92M | 0.01% |
292,435
+10,000
| +4% | +$264K |
|
1595
Safe Bulkers
SB
$790M
| $7.9M | 0.01% |
4,648,389
+227,403
| +5% | +$395K |
|
|
ACOR
1596
DELISTED
Acorda Therapeutics
ACOR
| $7.87M | 0.01% |
32,144
-1,659
| -5% | -$419K |
|
|
TGE
1597
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $7.87M | 0.01% |
+355,538
| New | +$6.82M |
|
1598
Elbit Systems
ESLT
$36.6B
| $7.85M | 0.01% |
50,600
-28,100
| -36% | -$4.58M |
|
|
GSS
1599
DELISTED
Golden Star Resources Ltd.
GSS
| $7.82M | 0.01% |
2,051,660
-332,936
| -14% | -$1.06M |
|
1600
Xenon Pharmaceuticals
XENE
$6.02B
| $7.81M | 0.01% |
595,677
+107,077
| +22% | +$1.13M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.